Media OutReach
HKSTP Teams Up with HKU and CUHK Medical Schools to Showcase Hong Kong’s Life & Health Innovations at BIO International Convention
Seizing Global Business and Investment Opportunities for Sustainable Growth
HONG KONG SAR – Media OutReach Newswire – 17 June 2025 – Hong Kong Science and Technology Parks Corporation (HKSTP), in collaboration with InvestHK, led 16 prominent life and health technology companies to BIO 2025, the world’s largest biotechnology event, held in Boston, USA, from June 16 to 19. This year marks the first time HKSTP joined forces with Hong Kong’s two leading medical faculties—the LKS Faculty of Medicine at The University of Hong Kong (HKU) and the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) – to form a delegation, showcasing Hong Kong’s cutting-edge research capabilities and innovation potential in life sciences and health technologies. The initiative further strengthens Hong Kong’s position as a world-class biotech innovation hub.
The HKSTP Pavilion highlighted the groundbreaking technologies and products of its park companies, featuring innovative solutions across diverse fields such as novel drug development, diagnostic technologies, and medical innovation. Among the 16 participating companies, they were the members of HKSTP’s incubation programmes including Incu-Bio and ELITE Programme, cutting-edge work from the InnoHK research centers, and other outstanding biotech companies. On the first day of the exhibition, the delegation successfully attracted attention from global industry leaders, corporate partners, and venture capital firms.
During BIO 2025, HKSTP and its park companies made significant strides in fostering cross-border innovation ecosystems and exploring new market opportunities:
- Immuno Cure, partnering with HKUMed, the developer of the first-in-human novel therapeutic HIV vaccine ICVAX, announced its collaboration with PharmaJet to explore the application of a needle-free vaccination solution, accelerating the global commercialization pathway for ICVAX.
- HKSTP signed a partnership agreement with DLRC to provide legal advisory services in clinical trials and certification, promoting global ecosystem collaboration and growth.
Mr. Albert Wong, CEO of HKSTP, said: “We are thrilled to partner with two leading medical schools for the first time at BIO 2025, demonstrating Hong Kong’s breakthroughs and innovation in life and health technology. This delegation not only deepens collaboration between Hong Kong and top global research institutions but also highlights our unique advantages as a core I&T hub in the Greater Bay Area. With strong policy and funding support from the HKSAR government, Hong Kong will further serve as a bridge connecting Mainland China and global tech partnerships, solidifying its leadership in life sciences innovation.”
Ahead of BIO 2025, the delegation participated in the “2025 Biomedical Pitch Competition”, co-organized by the Boston Capital Investment Club (BCIC) and HKSTP. The event connects global life and health innovators with investors and business partners. Three HKSTP companies—ARBELE, GenEditBio, and Cogsmart—excelled in the preliminary rounds, competing against over 100 global life sciences firms, with ARBELE, HKUMed’s affiliated spin-off company, winning the championship, underscoring Hong Kong’s research excellence. Over the past three years, this platform has helped startups secure over USD 100 million in funding and connect with hundreds of international investors and partners, driving further business growth.
HKSTP is committed to propelling Hong Kong’s life sciences sector onto the global stage, showcasing the city’s unique strengths to attract international enterprises and talent. The delegation also organized networking events and visits, enabling Hong Kong companies to engage with overseas investors, leading corporations, and renowned academic institutions, including visits to MIT Professor Robert Langer (Described as “Edison of Medicine”), Harvard Innovation Labs, Cambridge Innovation Center, and more. This initiative reinforces Hong Kong’s sustainable development in life sciences and its role as a global innovation leader.
Appendix: List of Park Companies Participating in BIO 2025:
- Allegrow Biotech Limited
- ARBELE Limited
- Beth Bioinformatics Co., Limited
- Centre for Translational Stem Cell Biology
- The Centre for Virology, Vaccinology, and Therapeutics
- DECODE CURE Limited
- GenEditBio Limited
- Great Bay Bio
- Hong Kong Universal Biologicals Company Limited
- Immuno Cure Holding (HK) Limited
- The Institute for Innovation, Translation and Policy Research (ITPR)
- LEE’S PHARMACEUTICAL (HK) LIMITED
- Serilink Biotechnology Company Limited
- Xiaomo Biotech Limited
- XUXIN (HongKong) Biotechnology Co., Limited
- Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited
Hashtag: #HKSTP
The issuer is solely responsible for the content of this announcement.
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 13 unicorns, more than 15,000 research professionals and over 2,300 technology companies from 25 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.
Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Pak Shek Kok, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.
Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.
Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues to contribute in stablishing I&T as a pillar of growth for Hong Kong. More information about HKSTP is available at
www.hkstp.org.
Media OutReach
A First in the Asia-Pacific – Taiwan Leads the Launch of the Early Kidney Disease Annual Report, Opening a New Era in Advancing Kidney Care
- Yung-Ho Hsu, Secretary General of the Taiwan Society of Nephrology
- Shang-Jyh Hwang, Honorary President of the Taiwan Society of Nephrology
- Masaomi Nangaku, Immediate Past-President of the International Society of Nephrology
- Marcello Tonelli, President of the International Society of Nephrology
- Mai-Szu Wu, President of the Taiwan Society of Nephrology
- Chung-Liang Shih, Minister of the Ministry of Health and Welfare
- Ching-Fen Shen, Director General of the Health Promotion Administration, Ministry of Health and Welfare
- Chih-Cheng Hsu, Professor at the National Health Research Institutes
- Hyeong-Cheon Park, President Elect of the Asia Pacific Society of Nephrology
- Rajnish Mehrotra, President of the International Society of Peritoneal Dialysis
The complete and immediate analysis aids in reversing the past trend where most patients were diagnosed at late stages and required dialysis, ushering in a new era of early detection and treatment. Minister of Health and Welfare, Chung-Liang Shih, stated at a press conference that this annual report serves as a new engine for promoting precise care, integrating complete data and risk classification indicators for Early CKD P4P(Pay for Performance) and Pre-ESRD P4P. This fills the gap in early kidney disease data and strengthens the quantitative basis for policy and clinical decision-making, facilitating early intervention and delaying disease progression. The goal is to achieve the Healthy Taiwan Policy target of reducing the standardized mortality rate for chronic diseases by one-third by 2030, and for Taiwan’s care model to become an example in the Asia-Pacific, establishing a sustainable and precise new framework for kidney care.
The early kidney disease annual report reveals several key trends. According to KDIGO risk classification, the proportion of high-risk and very high-risk patients in the P4P program has gradually decreased in recent years, reflecting a shift in treatment strategies toward early intervention and prevention. This trend not only highlights the medical team’s emphasis on the care of early-stage chronic kidney disease patients but also helps delay disease progression and reduce the incidence of later-stage complications. In terms of controlling the “three highs” (hyperglycemia, hypertension, and hyperlipidemia), data shows that approximately 80% of patients meet lipid targets and nearly 60% maintain stable blood sugar levels. However, only about 30% meet the target for blood pressure below 130/80 mmHg, indicating significant challenges remain in blood pressure control. The “three highs” are important risk factors for the progression and deterioration of chronic kidney disease, making it crucial to further improve control rates. The implementation of the P4P program has already shown preliminary results, and there are expectations for more immediate, comprehensive, and rigorous data collection and tracking, which will more fully demonstrate the long-term benefits of this care model.
Data-Driven: Taiwan’s First Early Kidney Disease Annual Report Fills Care Gaps
Professor Chih-Cheng Hsu from the National Health Research Institutes pointed out that past domestic kidney disease care has primarily focused on dialysis and end-stage disease, with limited understanding of early stages and delayed updates on data. This annual report breaks through traditional reporting frameworks and represents the first integration of complete data and risk classification indicators for Early CKD P4P and Pre-ESRD P4P. Utilizing big data for in-depth analysis, it outlines the disease progression and comorbidity trends of patients at different risk levels, successfully filling the long-term gap in early kidney disease care. He noted that grasping information on early stages of disease helps clinicians intervene earlier and delay deterioration while providing quantitative evidence for health policies to promote proactive and timely kidney care strategies, enhancing Taiwan’s international competitiveness in precise health governance.
Early CKD P4P and Pre-ESRD P4P are two phased quality-based reimbursement programs promoted by the National Health Insurance Administration, addressing key care needs for early chronic kidney disease and pre-dialysis patients, respectively. Early CKD P4P primarily targets patients in CKD stages 1-3a, aiding healthcare institutions in early identification of kidney deterioration risks through disease tracking and integrated care models, providing personalized management. Pre-ESRD P4P focuses on patients in CKD stages 3b, 4-5, enhancing control of complications, medication, and nutritional management while utilizing data feedback to support treatment decisions, aiming to delay dialysis and improve care efficiency. Both programs link the complete processes from early prevention to pre-dialysis intervention, contributing to improved overall CKD care quality and patient long-term prognosis.
Precise Kidney Care: Holistic and Continuous CKD Care as a Model for Chronic Disease
Taiwan centers its approach on “precise care,” continuously optimizing the integrated chronic kidney disease care system to implement policy blueprints in clinical practice. Director General of National Health Insurance Administration, Lian-Yu Chen, mentioned that Taiwan has progressively refined various measures, from educational programs for pre-end-stage renal disease patients to integrated care plans for early chronic kidney disease. The medical team can adjust personalized treatment strategies based on patient risk classification and clinical data, strengthening disease management and follow-up effectiveness for early-stage patients. She indicated that by integrating and providing feedback across units, care gaps could be minimized to ensure that patients receive consistent medical services across different levels of care. Director General of Health Promotion Administration, Ching-Fen Shen, remarked that grassroots health education and community health advocacy go hand in hand to enhance public awareness of kidney health. Years of efforts have significantly slowed the deterioration of early kidney disease progression, with patients participating in integrated care exhibiting a lower future risk of dialysis compared to those who do not participate, showing tangible effectiveness of the Taiwan model.
Policy Linkage and Sustainable Vision: Achieving the Healthy Taiwan Goals and Leading the New Landscape of Asia-Pacific
In response to the government’s “Healthy Taiwan” policy, Taiwan is implementing a preventive kidney care model based on the Early CKD P4P and Pre-ESRD P4P systems and the Early Kidney Disease Annual Report. President of the Taiwan Society of Nephrology, Mai-Szu Wu, stated that investing in early chronic kidney disease management not only contributes to health sustainability but also reduces waste of medical resources, achieving dual benefits of health outcomes and environmental sustainability, assisting the government in its goal to reduce chronic disease mortality by one-third by 2030.
During the Asia-Pacific Nephrology Conference (APCN) held in Taipei this year, the Asia-Pacific’s first Early Kidney Disease Annual Report was officially unveiled. President of the International Society of Nephrology, Marcello Tonelli, and Immediate Past-President , Masaomi Nangaku, along with the President Elect of the Asia Pacific Society of Nephrology Hyeong-Cheon Park and Honorary Secretary Sunita Bavanandan attended as witnesses, attracting experts from South Korea, Japan, Thailand, Malaysia, Australia, New Zealand, Singapore, Hong Kong, Mongolia, Indonesia, and the Philippines. Additionally, various important domestic academic societies, including the Taiwan Academy of Family Medicine, Taiwan Society of Cardiology, the Diabetes Association of the Republic of China (Taiwan), the Taiwan Association of Clinical Diabetes, and the Taiwan Medical Clinics Association also participated and supported the event. Minister Chung-Liang Shih expressed gratitude for the collective efforts and emphasized that this kidney annual report showcases Taiwan’s leading position in medical data integration and clinical evidence, hoping that real-time and comprehensive data analysis will once again showcase Taiwan’s precision care model to the international community, working together with other countries to create a new global framework for chronic kidney disease prevention and treatment.
Hashtag: #TaiwanSocietyofNephrology
The issuer is solely responsible for the content of this announcement.
Media OutReach
The Government of Angola Launches an International Public Tender for the Management of the Namibe Corridor
The concession, with an initial duration of 30 years, extendable up to 50 years, covers the operation, management, maintenance and preservation of the Moçâmedes–Menongue Railway Line, including rolling stock, associated infrastructure, workshops and the training centre. It further encompasses the possibility of designing and constructing new sections, extensions and branch lines, as well as railway connections to the Republic of Namibia and, at a later stage, to the Republic of Zambia.
The Secretary of State for Land Transport, Jorge Bengue, noted at the launch event that the process constitutes a strategic opportunity for international operators with a proven track record in the railway sector. “The Namibe Corridor has the potential to strengthen Angola’s role as a regional logistics platform, enhance supply chains, foster new investments, and increase the competitiveness of exports. We anticipate a dynamic tender process with strong participation from established industry operators,” he stated.
Jorge Bengue further emphasised that Angola has carried out structural reforms in recent years that have strengthened legal certainty and created a more competitive business environment. The success of the concession of the Lobito Corridor has demonstrated the country’s capacity to implement partnership models that stimulate private investment and accelerate the modernization of transport infrastructure.
Individual companies or consortiums of competitors with proven experience in the management of railway infrastructure and freight operations are eligible to apply. The detailed technical and financial requirements are set out in the tender documents, which are available for a fee of USD 20,000, or the equivalent in kwanzas at the exchange rate of the National Bank of Angola at the time of the transaction.
The Namibe Corridor encompasses the Moçâmedes Railway, with a total length of 855 km, and the Port of Namibe, forming a strategic logistics axis for the export of minerals, ornamental stones, agricultural products, and other goods. The infrastructure allows for a theoretical capacity of up to 5 million tonnes per year, serving as a connection point for landlocked countries in the region, in coordination with the Lobito and Walvis Bay corridors.
This corridor also contributes to tourism development and regional integration, strengthening Angola’s position in Atlantic–Indian trade routes and consolidating the country as a significant commercial hub within the African context.
Distributed by APO Group on behalf of Ministry of Transport of Angola.
Download Image: https://apo-opa.co/48GQeet
Caption: The official launch of the Public Tender, presided over by the Secretary of State for Land Transport, Jorge Bengue
The issuer is solely responsible for the content of this announcement.
Media OutReach
VinFast VF 8 – Crafted for high-expectation markets in the GCC
Premium design meets industry-leading warranty and long-term support
DUBAI, UAE – Media OutReach Newswire – 12 December 2025 – The Middle East’s electric vehicle market is still developing but advancing quickly. In the Gulf Cooperation Council (GCC) region, EV sales penetration doubled from about 2 per cent to roughly 4 per cent in just one year, placing the region among the fastest-growing EV markets globally. 91% of battery-electric vehicle owners here say they plan to buy another EV, above the global average of 87%.
Amid that backdrop, buyers are seeking vehicles that match or exceed the space, performance, and refinement expected from premium SUVs. VinFast VF 8 arrives as a direct response to these elevated expectations, combining sophisticated design, robust capability, and a comprehensive ownership framework built around long-term confidence.
The VF 8 is shaped by VinFast’s “Dynamic Balance” design philosophy, a deliberate interplay between flowing curves and precise, angular lines that creates a sense of energy and visual structure without sacrificing harmony. This design language feels both contemporary and enduring. The result is a vehicle that projects presence without aggression, offering an aesthetic that balances boldness with sophistication, qualities that resonate with Middle Eastern consumers who view their vehicles as reflections of personal standards.
Under the sculpted exterior lies engineering tuned for high-demand regional driving. The VF 8 Plus variant delivers all-wheel drive with up to 402 horsepower and 620 Nm of torque, accelerating from 0 to 100 kph in under 5.5 seconds. This translates to confident overtaking on high-speed highways, assured merging in dense urban traffic, and the capability to handle extended cruising. Range reaches up to 493 km (NEDC) in the Eco configuration, a practical threshold aligned with intercity travel patterns across the region.
The 15.6-inch infotainment display provides intuitive access to navigation and vehicle settings. Crucially for the region, dual-zone climate control paired with ventilated seats are essential features designed to maintain cabin comfort even during peak heat.
The VF 8 integrates a comprehensive suite of smart systems designed to reduce driver workload. Traffic Jam Assist manages stop-and-go driving in congested environments, easing the fatigue of gridlock. Highway Assist supports sustained motorway cruising, helping drivers maintain lane position during long-distance travel. These systems work together to create a driving experience that feels more secure and less demanding.
Where the VF 8 truly distinguishes itself is in VinFast’s approach to long-term ownership. Addressing anxieties around battery longevity and service maturity, VinFast offers what may be the industry’s most comprehensive warranty structure. The VF 8 comes with a 10-year/200,000-km vehicle warranty and a 10-year unlimited-kilometer battery warranty, and 5-year/100,000-km of free service, eliminating one of the primary concerns of electric vehicle ownership. It’s also supported by practical service infrastructure: mobile service capabilities bring maintenance to customers’ locations, while 24/7 roadside assistance ensures support is available whenever needed.
The VF 8 represents VinFast’s understanding that success in sophisticated markets like the GCC requires vehicles that genuinely align with how people live, drive, and make long-term decisions. For Middle Eastern buyers navigating the transition to electric mobility, the VF 8 offers confidence in all aspects: design, performance, comfort, and warranty support. From the first drive to years down the road, it’s an electric vehicle crafted to deliver peace of mind alongside capability.
Hashtag: #VinFast
The issuer is solely responsible for the content of this announcement.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism9 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking7 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn











